Dr Arun Azad |
Medical
oncologist and researcher Dr Arun Azad is the recipient of a prestigious Victorian
Cancer Agency Clinical Research Fellowship, announced last week by Minister for
Health, the Hon Jill Hennessy MP.
The
highly competitive Fellowship worth $800,000 over four years will enable to Dr
Azad to characterise the effects of docetaxel chemotherapy on
castration-sensitive prostate cancer.
“In collaboration with Professor Gail Risbridger in the School of Biomedical Sciences, I will investigate whether
docetaxel targets a population of ‘pre-existing’ castration-resistant cells,”
said Dr Azad.
“This
work may identity novel ways of making docetaxel more effective in
castration-sensitive prostate cancer, paving the way for future clinical trials
and better patient outcomes.”
An
early-career medical oncologist and translational researcher in genitourinary
malignancies, Dr Azad led cutting-edge work investigating mechanisms of
therapeutic resistance and response in advanced prostate cancer patients
through genomic analysis of circulating cell-free DNA (cfDNA) at the British
Columbia Cancer Agency, Vancouver, Canada.
Dr
Azad has played an active role in the development of 5 investigator-initiated
clinical trials and been the recipient of over $1.5M in competitive funding
including a prestigious CJ Martin Fellowship from the NH&MRC. His clinical
and research activities have resulted in publications in high-impact journals
including Journal of Clinical Oncology, European Urology and Lancet
Oncology. He has also been the recipient of 15 competitive prizes and
awards including Merit Awards at the American Society of Clinical Oncology
Annual Scientific Meeting and Genitourinary Cancers Symposium.
Dr
Azad will take up appointments at Monash Health and Monash University’s School of Clinical Sciences (SCS) later this year to focus on
pre-clinical and clinical translational research in genitourinary cancers.
No comments:
Post a Comment